ChemicalBook--->CAS DataBase List--->1123837-84-2

1123837-84-2

1123837-84-2 Structure

1123837-84-2 Structure
IdentificationBack Directory
[Name]

Sitravatinib
[CAS]

1123837-84-2
[Synonyms]

MG516
CS-2638
MGCD-516
Sitravatinib
Sitravatinib (MGCD516)
N-(3-fluoro-4-((2-(5-(((2-methoxyethyl)amino)methyl)pyridin-2-yl)thieno[3,2-b]pyridin-7-yl)oxy)phenyl)-N-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide
1,1-Cyclopropanedicarboxamide, N-[3-fluoro-4-[[2-[5-[[(2-methoxyethyl)amino]methyl]-2-pyridinyl]thieno[3,2-b]pyridin-7-yl]oxy]phenyl]-N'-(4-fluorophenyl)-
[Molecular Formula]

C33H29F2N5O4S
[MDL Number]

MFCD28502181
[MOL File]

1123837-84-2.mol
[Molecular Weight]

629.68
Chemical PropertiesBack Directory
[Boiling point ]

833.5±65.0 °C(Predicted)
[density ]

1.417±0.06 g/cm3(Predicted)
[storage temp. ]

-20°C
[solubility ]

Soluble in DMSO (up to at least 25 mg/ml), or in Ethanol (up to at least 25 mg/ml)
[form ]

solid
[pka]

13.17±0.70(Predicted)
[color ]

Off-white
[Stability:]

Stable for 1 year from date of purchase as supplied. Solutions in DMSO or ethanol may be stored at -20°C for up to 1 month.
[InChIKey]

WLAVZAAODLTUSW-UHFFFAOYSA-N
[SMILES]

C1(C(NC2=CC=C(F)C=C2)=O)(C(NC2=CC=C(OC3C=CN=C4C=C(C5=NC=C(CNCCOC)C=C5)SC4=3)C(F)=C2)=O)CC1
Hazard InformationBack Directory
[Description]

Sitravatinib, known as MGCD516, is a multikinase (MET, RET, AXL, NTRK1, or NTRK3 genes) inhibitor used in a phase 1/1b clinical trial (NCT02219711) for patients with advanced cancers (NCT02219711).
[Uses]

MGCD 516 is an intermediate used to prepare substituted thienopyridines as inhibitors of protein tyrosine kinase activity.
[Synthesis]

Carbamic acid, N-[[6-[7-[2-fluoro-4-[[[1-[[(4-fluorophenyl)amino]carbonyl]cyclopropyl]carbonyl]amino]phenoxy]thieno[3,2-b]pyridin-2-yl]-3-pyridinyl]methyl]-N-(2-methoxyethyl)-, 1,1-dimethylethyl ester

1123837-39-7

Sitravatinib

1123837-84-2

Step 2. Synthesis of N-(3-fluoro-4-((2-(5-(((2-methoxyethyl)amino)methyl)pyridin-2-yl)thieno[3,2-b]pyridin-7- yl)oxy)phenyl)-N-(4-fluorophenyl)cyclopropane-1,1 -dicarboxamide (147): Compound 146 (0.59 g, 0.81 mmol) was dissolved in dichloromethane (50 mL) in dichloromethane (50 mL) and trifluoroacetic acid (TFA, 3 mL) was added. The reaction mixture was stirred at room temperature for 18 hours. Upon completion of the reaction, the solution was concentrated to remove the solvent. The residue was partitioned between dichloromethane and 1 M sodium hydroxide solution and filtered to remove insoluble impurities. The organic phase was separated, washed sequentially with 1 M sodium hydroxide solution and saturated brine, dried over anhydrous magnesium sulfate, filtered and concentrated to afford the target compound 147 (0.35 g, 69% yield).1H NMR (400 MHz, DMSO-d6) δ (ppm): 10.40 (s, 1H), 10.01 (s, 1H), 8.55 (d, J = 1.6 Hz 1H), 8.51 (d, J = 5.3 Hz, 1H), 8.31 (s, 1H), 8.22 (d, J = 8.0 Hz, 1H), 7.92-7.87 (m, 2H), 7.65-7.61 (m, 2H), 7.52-7.43 (m, 2H), 7.17-7.12 (m, 2H), 6.64 (d, J = 5.5 Hz, 1H), 3.77 (s, 2H), 3.40 (t, J = 5.7 Hz, 2H), 3.23 (s, 3H), 2.64 (t, J = 5.7 Hz, 2H), 1.46 (br s, 4H). Mass spectrum (m/z): 630.1 (M + H).

[in vivo]

Sitravatinib (20 mg/kg; p.o.; once per day for 6 days) significantly inhibits tumor progression and induces tumor regression in C57BL/6 mice bearing CT1B-A5 cells model[2].

Animal Model:6-week-old C57BL/6 mice (bearing CT1B-A5 cells) [2]
Dosage:20 mg/kg
Administration:Oral administration; once per day for 6 days
Result:Significantly inhibited tumor progression and induced tumor regression.
[IC 50]

Axl: 1.5 nM (IC50); MER: 2 nM (IC50); VEGFR3: 2 nM (IC50); VEGFR2: 5 nM (IC50); VEGFR1: 6 nM (IC50); TrkA: 5 nM (IC50); TrkB: 9 nM (IC50); KIT: 6 nM (IC50); FLT3: 8 nM (IC50); DDR2: 0.5 nM (IC50); DDR1: 29 nM (IC50)
[storage]

Store at -20°C
[References]

1) Parag?et al.?(2016)?Significant blockade of multiple receptor kinases by MGCD516 (Sitravatinib), a novel small molecule inhibitor, shows potent anti-tumor activity in preclinical models of sarcoma; Oncotarget?7?4093 2) Leal?et al.?(2017)?Evidence of clinical activity of sitravatinib in combination with nivolumab in NSCLC patients progressing on prior checkpoint inhibitors; J. Thorac. Oncol.?12?S1803 3) Du?et al.?(2018);?Sitravatinib potentiates immune checkpoint blockade in refractory cancer models; JCI Insight?3?124184
Spectrum DetailBack Directory
[Spectrum Detail]

Sitravatinib(1123837-84-2)1HNMR
1123837-84-2 suppliers list
Company Name: Suzhou Meidi Senuo Pharmaceutical Technology Co., Ltd.  Gold
Telephone: 13771642864
Website: https://www.chemicalbook.com/ShowSupplierProductsList1659441/0_EN.htm
Company Name: Dalian Meilun Biotech Co., Ltd.  
Telephone: 0411-62910999 13889544652
Website: http://www.meilunbio.com/
Company Name: Bide Pharmatech Ltd.  
Telephone: 400-164-7117 18317119277
Website: www.bidepharm.com
Company Name: Shanghai Lollane Biological Technology Co.,Ltd.  
Telephone: 021-52996696,15000506266 15000506266
Website: http://www.bioll.com
Company Name: Shanghai YuanYe Biotechnology Co., Ltd.  
Telephone: 15026964105
Website: www.shyuanye.com
Company Name: Qingdao IniKem BioPharmaTech Co.,Ltd  
Telephone: 0532-58268781 18561687109
Website: https://www.inikem.com
Company Name: ShangHai Biochempartner Co.,Ltd  
Telephone: 177-54423994 17754423994
Website: www.biochempartner.com
Company Name: Shanghai Zhixin Chemical Technology Co., Ltd.  
Telephone: 18701958033
Website: http://www.shzxchem.com
Company Name: Amadis Chemical Company Limited  
Telephone: 571-89925085
Website: http://www.amadischem.com
Company Name: Zhongshan Geometric Biological Technology Co., Ltd.  
Telephone:
Website: www.chemicalbook.com/ShowSupplierProductsList19931/0_EN.htm
Company Name: Chuzhou KeMail Chemical Technology Co., Ltd  
Telephone: 0550-5196001 15000891977
Website: https://www.chemicalbook.com/ShowSupplierProductsList19947/0_EN.htm
Company Name: Kaixin Chemical (Hong Kong) Limited  
Telephone: 010-88886666-01 13112345678
Website: www.kxpharm.com
Company Name: Twochem Co.Ltd.  
Telephone: 021-58111628 15800915896
Website: cn.twochem.com
Company Name: Zhengzhou Ruke Biological Co., Ltd.  
Telephone: 15981811963
Website: www.chemicalbook.com/showsupplierproductslist30552/0_en.htm
Company Name: Jinan Yaoyan Pharmaceutical Co., Ltd.  
Telephone:
Website: www.chemicalbook.com/ShowSupplierProductsList30574/0_EN.htm
Company Name: Shandong utilizing biological technology co., LTD  
Telephone: 18669728830 15966937598
Website: www.demaichem.com
Company Name: Shanghai Medicil Biomedical Co., Ltd.  
Telephone: 021-50822001
Website: www.chemicalbook.com/ShowSupplierProductsList30881/0_EN.htm
Company Name: Guangzhou Tomums Life Science Co., Ltd.  
Telephone: 020-31155029 18902330969
Website: http://www.tomums.cn/
Tags:1123837-84-2 Related Product Information
201677-61-4 106685-40-9 5812-07-7 30562-34-6 97322-87-7 1221485-83-1 210421-74-2